Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A new composite scale of MRI-defined disease severity in multiple sclerosis
Multiple Sclerosis
(-)
118
Authors/Disclosures
Mohit Neema, MD
PRESENTER
No disclosure on file
Antonia Ceccarelli, MD, PhD (Epicura Centre Hospitalier, VUB) No disclosure on file
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Bonnie Glanz (Brigham and Women'S Hospital) The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Shahamat Tauhid, MD (Brigham & Women's Hospital) Dr. Tauhid has nothing to disclose.
Gloria Kim (Brigham & Womens Hospital) No disclosure on file
Jennifer R. Miller No disclosure on file
Rohit Bakshi, MD, FAAN Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. An immediate family member of Dr. Bakshi has received stock or an ownership interest from Biogen. The institution of Dr. Bakshi has received research support from BMS/Celgene. The institution of Dr. Bakshi has received research support from EMD Serono.
Neill R. Graff-Radford, MD, FAAN (Mayo Clinic Jacksonville) The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Novartis. The institution of Dr. Graff-Radford has received research support from AbbVie. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.